Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
BMC Cancer|June 6, 2022
The role of sentinel node tumor burden in modeling the prognosis of melanoma patients with positive sentinel node biopsy: an Italian melanoma intergroup study (N = 2,086)Saveria Tropea, Paolo Del Fiore, Andrea Maurichi, et al.
Cancer Immunology, Immunotherapy : CII|April 17, 2013
Effects of cyclophosphamide and IL-2 on regulatory CD4+ T cell frequency and function in melanoma patients vaccinated with HLA-class I peptides: impact on the antigen-specific T cell responseChiara Camisaschi, Paola Filipazzi, Marcella Tazzari, et al.
The Lancet. Oncology|April 18, 2025
Clinical validation of droplet digital PCR assays in detecting BRAFV600-mutant circulating tumour DNA as a prognostic biomarker in patients with resected stage III melanoma receiving adjuvant therapy (COMBI-AD): a biomarker analysis from a double-blind, randomised phase 3 trialMahrukh M Syeda, Georgina V Long, James Garrett, et al.
The Oncologist|August 6, 2021
Liquid Biopsy and Radiological Response Predict Outcomes Following Discontinuation of Targeted Therapy in Patients with BRAF Mutated MelanomaLorenza Di Guardo, Giovanni Randon, Francesca Corti, et al.
The New England Journal of Medicine|September 3, 2020
Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III MelanomaReinhard Dummer, Axel Hauschild, Mario Santinami, et al.
Oncotarget|December 20, 2015
Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125bElisabetta Vergani, Lorenza Di Guardo, Matteo Dugo, et al.
The Journal of Investigative Dermatology|June 1, 2022
Genetic Layout of Melanoma Lesions Is Associated with BRAF/MEK-Targeted Therapy Resistance and Transcriptional ProfilesElisabetta Vergani, Adele Busico, Matteo Dugo, et al.
Cancer Research|January 8, 2014
Transcriptional profiling of melanoma sentinel nodes identify patients with poor outcome and reveal an association of CD30(+) T lymphocytes with progressionViviana Vallacchi, Elisabetta Vergani, Chiara Camisaschi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2014
Prediction of survival in patients with thin melanoma: results from a multi-institution studyAndrea Maurichi, Rosalba Miceli, Tiziana Camerini, et al.
European Journal of Cancer (Oxford, England : 1990)|August 3, 2020
Timing of sentinel node biopsy independently predicts disease-free and overall survival in clinical stage I-II melanoma patients: A multicentre study of the Italian Melanoma Intergroup (IMI)Mario Mandalà, Francesca Galli, Roberto Patuzzo, et al.
Pageof 11